SARAH LEMOINE: Open Payments
NPI 1669028429 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 31 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $998 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $325 |
| GENZYME CORPORATION | 4 | $134 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $119 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $115 |
| Renalytix AI, Inc. | 5 | $85 |
| ABBVIE INC. | 4 | $74 |
| Exact Sciences Corporation | 1 | $22 |
Products named: DUPIXENT, REPATHA, KRYSTEXXA, REXULTI, Epclusa, CAPLYTA, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, VRAYLAR.
Industry payments across LA — which companies pay providers there.
